Circulating tumor DNA methylation marker-based minimal residual diseases detection and recurrence monitoring of cancer

被引：0
|
作者：
Wang, Huiyong
Pan, Xiaobao
Wang, Lin
Li, Chao
Ma, Chao
Yu, Shuai
Meng, Fanyang
Liu, Jing
Liu, Liang
Cao, Zhanbo
机构：
[1] Smartquerier Gene Technol Shanghai Co Ltd, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Pancreat Surg, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15172
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Next-generation sequencing of circulating tumor DNA for detecting minimal residual disease and predicting recurrence in colorectal cancer patients
    Chan, Hiu Ting
    Nagayama, Satoshi
    Chin, Yoon Ming
    Otaki, Masumi
    Hayashi, Rie
    Kiyotani, Kazuma
    Fukunaga, Yosuke
    Ueno, Masashi
    Nakamura, Yusuke
    Low, Siew-Kee
    CLINICAL CANCER RESEARCH, 2020, 26 (11) : 58 - 58
  • [42] Circulating tumor DNA-based molecular residual disease detection for the monitoring of high-grade serous ovarian cancer
    Wang, Xipeng
    Ying, Xiang
    Wang, Yizhi
    Zheng, Xiaocui
    Li, Jiarui
    Li, Xing
    Wang, Kai
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A209 - A209
  • [43] Circulating tumor DNA (ctDNA) as a prognostic marker for recurrence in resected pancreas cancer.
    Wang, Judy Sing-Zan
    Sausen, Mark
    Parpart-Li, Sonya
    Murphy, Derek M.
    Velculescu, Victor E.
    Wood, Laura D.
    Solt-Linville, Sara
    Sugar, Elizabeth
    Bartlett, Bjarne
    Blair, Cherie
    Dauses, Tianna
    Jaffee, Elizabeth M.
    Hruban, Ralph H.
    Laheru, Dan
    Diaz, Luis A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [44] Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases
    Marmorino, Federica
    Prisciandaro, Michele
    Giordano, Mirella
    Ortolan, Elisa
    Crucitta, Stefania
    Manca, Paolo
    Antoniotti, Carlotta
    Valenti, Marta Maria
    Danesi, Romano
    Conca, Veronica
    Mazzoli, Giacomo
    Boccaccino, Alessandra
    Carullo, Martina
    Martinetti, Antonia
    Sottotetti, Elisa
    Masi, Gianluca
    Sposito, Carlo
    Zaffaroni, Nadia
    Milione, Massimo
    Fontanini, Gabriella
    Del Re, Marzia
    Pietrantonio, Filippo
    Cremolini, Chiara
    JCO PRECISION ONCOLOGY, 2022, 6
  • [45] Circulating tumor DNA-guided minimal residual disease assessment in colorectal cancer
    Chakrabarti, Sakti
    Mahipal, Amit
    PHARMACOGENOMICS, 2023,
  • [46] Circulating Tumor DNA Testing for Minimal Residual Disease and Its Application in Colorectal Cancer
    Abidoye, Oluseyi
    Ahn, Daniel H.
    Borad, Mitesh J.
    Wu, Christina
    Bekaii-Saab, Tanios
    Chakrabarti, Sakti
    Sonbol, Mohamad Bassam
    CELLS, 2025, 14 (03)
  • [47] Sensitive circulating tumor DNA-based residual disease detection in epithelial ovarian cancer
    Kallio, Heini M. L.
    Savolainen, Kalle
    Virtanen, Tuomo
    Ryyppo, Lauri
    Selin, Hanna
    Martikainen, Paivi
    Staff, Synnove
    Kivinummi, Kati
    Sipola, Joonatan
    Vuorinen, Juuso
    Nikkola, Jussi
    Nykter, Matti
    Auranen, Annika
    Annala, Matti
    LIFE SCIENCE ALLIANCE, 2024, 7 (06)
  • [48] Circulating free DNA: a new surrogate marker for minimal residual disease?
    Fehm, Tanja
    Banys, Malgorzata
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (01) : 119 - 122
  • [49] Circulating free DNA: a new surrogate marker for minimal residual disease?
    Tanja Fehm
    Malgorzata Banys
    Breast Cancer Research and Treatment, 2011, 130 : 119 - 122
  • [50] Methylation of miRNA genes as a urinary DNA marker for detection and prediction of bladder cancer recurrence
    Suzuki, Hiromu
    Shindo, Tetsuya
    Nojima, Masanori
    Shimizu, Takashi
    Niinuma, Takeshi
    Kitajima, Hiroshi
    Kai, Masahiro
    Masumori, Naoya
    CANCER SCIENCE, 2018, 109 : 500 - 500
12345